Clinical Trial Update: Micronised Resveratrol as a Treatment for Friedreich Ataxia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating micronised resveratrol as a treatment for Friedreich's ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Micronised Resveratrol (resveratrol)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED